Dr. Lauren Sharan Ranard, MD

Dr. Ranard practices at Columbia University Irving Medical Center in New York, New York.

Dr. Ranard's NPI, 1437512860, was assigned on April 2, 2016. Dr. Ranard graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 2016. Dr. Ranard holds New York license 298387.

Dr. Ranard's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Ranard's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Ranard is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Ranard to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ranard practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Ranard's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Ranard is licensed in New York.

CMS data shows 138 Medicare services from Dr. Ranard across 1 procedure code in 2024, for 61 Medicare patients. Medicare paid $9,459 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Ranard in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have heart failure, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ranard's median patient age at 77, with 47% women.

In 2024, Dr. Ranard wrote 237 Medicare Part D claims for 53 patients. 78% of them were for generic drugs. CMS names the drug for 144 of them, across 8 drugs with 11 or more claims each, at $17,063 in total drug cost. In 2023, CMS named 134 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ranard for performance year 2024, reported through an alternative payment model (APM). Dr. Ranard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ranard as offering telehealth. CMS counts 15 procedures of coronary angioplasty and stenting by Dr. Ranard, more than 40% of the clinicians it reports for that procedure.

CMS Open Payments shows 93 general payments to Dr. Ranard from 18 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 49% of the total. Philips Electronics North America Corporation paid the most, $19,997.

Dr. Ranard graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 2016.